Nanoprobe and uses thereof
Patent Information
- Application Number
- TW114126069
- Authority / Receiving Office
- TW · TW
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-07-09
- Publication Date
- 2026-10-21
- Estimated Expiration
- 2045-07-08
Smart Images

Figure TWG2TB001917286_001 
Figure TWG2TB001917286_002 
Figure TWG2TB001917286_003
Abstract
Claims
1. A nanoprobe comprising: a magnetic nanoparticle (MNP) core; and a coating layer covering the magnetic nanoparticle core, the coating layer comprising: fucoidan or a derivative thereof; gelatin or a derivative thereof; and a cationic macromolecule.
2. The nanoprobe of claim 1, wherein the cationic macromolecule is selected from the group consisting of cationic polysaccharides, cationic polypeptides, and cationic proteins.
3. The nano probe as requested in claim 2, wherein the cationic macromolecule is protamine.
4. The nano probe of claim 1, wherein the weight ratio of the magnetic nanoparticles: the fucoidan or its derivatives: the gelatin or its derivatives: the cationic macromolecule is about 0-3:0.5-3:0-5:0.1-2.
5. The nano probe of claim 4, wherein the weight ratio of the magnetic nanoparticles: the fucoidan or its derivatives: the gelatin or its derivatives: the cationic macromolecule is about 1.35:0.8:1.6:0.
6.
6. The nano probe in request item 1 is a magnetic resonance imaging agent for thrombi.
7. Use of a nanoprobe as claimed in any one of claims 1 to 5 in the preparation of a contrast agent for magnetic resonance imaging.
8. Use of a nanoprobe as claimed in any one of claims 1 to 5 in the preparation of a pharmaceutical product for the detection or diagnosis of thrombosis-related diseases.
9. As requested in item 7, it is used to detect or diagnose the age and / or composition of thrombi.
10. As claimed in claim 8, wherein the thrombosis-related diseases include stroke, deep vein thrombosis, pulmonary embolism, and coronary thrombosis.
Citation Information
Patent Citations
Biocompatible magnetic materials
TW201936212A
Fucoidan-quaternized chitosan nanoparticles and application thereof
TW202108175A
Cell-nanoparticle drug delivery system and use of the same for inhibiting growth of tumor cells and diagnosing tumor cells
TW202410909A
